Delach; Scott
Patent Applications and Registrations
Patent applications and USPTO patent grants for Delach; Scott.The latest application filed is for "biomarkers associated with cdk inhibitors".
- Delach; Scott - Cambridge MA
- Delach; Scott - Waltham MA
| Patent | Date |
|---|---|
| Androgen receptor mutation Grant 10,011,874 - Caponigro , et al. July 3, 2 | 2018-07-03 |
| Biomarkers Associated With Cdk Inhibitors App 20180066322 - Caponigro; Giordano ; et al. | 2018-03-08 |
| Pharmaceutical combination comprising binimetinib Grant 9,867,825 - Caponigro , et al. January 16, 2 | 2018-01-16 |
| Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor Grant 9,700,557 - Caponigro , et al. July 11, 2 | 2017-07-11 |
| Novel Androgen Receptor Mutation App 20160002727 - CAPONIGRO; Giordano ; et al. | 2016-01-07 |
| Biomarkers Associated With Cdk Inhibitors App 20150322528 - Caponigro; Giordano ; et al. | 2015-11-12 |
| Pharmaceutical Combination Comprising Binimetinib App 20150313902 - CAPONIGRO; Giordano ; et al. | 2015-11-05 |
| Pharmaceutical Combinations of a CDK4/6 Inhibitor and a B-RAF Inhibitor App 20150164897 - Caponigro; Giordano ; et al. | 2015-06-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 